Fong L Y, Nguyen V T, Pegg A E, Magee P N
Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):191-9.
Alpha-difluoromethylornithine (DFMO) is an irreversible inhibitor of ornithine decarboxylase, the first enzyme in polyamine synthesis. Previous work showed simultaneous administration of DFMO and a zinc-deficient (ZD) diet to weanling rats from the beginning inhibited the onset of zinc-deficiency-induced esophageal cell proliferation by activating apoptosis and reduced the incidence of N-nitrosomethylbenzylamine (NMBA)-induced esophageal cancer. Because esophageal cancer initiation by NMBA is very rapid in ZD rats, this study determined whether DFMO is effective in preventing esophageal carcinogenesis when administered after the establishment of a carcinogenic environment. Weanling rats were given a ZD diet for 5 weeks to establish sustained increased esophageal cell proliferation and then an intragastric dose of NMBA. Thereafter, 20 rats were switched to DFMO-containing water while nine control ZD animals remained on deionized water; all of the animals continued on the ZD diet. Esophagi were collected 15 weeks later. The upper portion was processed for immunohistochemical analysis of cell proliferation, apoptosis, and expression of related genes, and the lower was processed for polyamine content. DFMO substantially reduces the levels of esophageal putrescine and spermidine and esophageal tumor incidence from 89 to 10% in ZD rats. Importantly, DFMO-treated ZD esophagi display increased rate of apoptosis accompanied by intense bax expression and greatly reduced cell proliferation by proliferating cell nuclear antigen expression. In addition, the p16(ink4a)/retinoblastoma control at G1 to S, deregulated in ZD esophagi, is restored after DFMO treatment. These results demonstrate that DFMO, a highly effective chemopreventive agent in esophageal carcinogenesis, reverses and counteracts esophageal cell proliferation/cancer initiation in ZD animals by way of stimulating apoptosis.
α-二氟甲基鸟氨酸(DFMO)是鸟氨酸脱羧酶的不可逆抑制剂,鸟氨酸脱羧酶是多胺合成过程中的首个酶。先前的研究表明,从断奶大鼠开始就同时给予DFMO和缺锌(ZD)饮食,可通过激活细胞凋亡来抑制缺锌诱导的食管细胞增殖的发生,并降低N-亚硝基甲基苄胺(NMBA)诱导的食管癌的发生率。由于在ZD大鼠中NMBA引发食管癌的速度非常快,因此本研究确定了在致癌环境形成后给予DFMO是否对预防食管癌有效。断奶大鼠接受ZD饮食5周,以建立持续增加的食管细胞增殖,然后给予胃内剂量的NMBA。此后,20只大鼠改用含DFMO的水,而9只对照ZD动物继续饮用去离子水;所有动物继续食用ZD饮食。15周后收集食管。上部用于细胞增殖、细胞凋亡及相关基因表达的免疫组化分析,下部用于多胺含量分析。DFMO可显著降低ZD大鼠食管中腐胺和亚精胺的水平以及食管癌的发生率,从89%降至10%。重要的是,经DFMO处理的ZD食管显示细胞凋亡率增加,同时bax表达强烈,通过增殖细胞核抗原表达显示细胞增殖大大减少。此外,在ZD食管中失调的G1至S期的p16(ink4a)/视网膜母细胞瘤控制在DFMO处理后得以恢复。这些结果表明,DFMO是食管癌发生过程中一种高效的化学预防剂,通过刺激细胞凋亡来逆转和对抗ZD动物食管细胞增殖/癌症起始。